메뉴 건너뛰기




Volumn 29, Issue SUPPL.3, 2013, Pages 33-39

Beyond gout: Uric acid and cardiovascular diseases

Author keywords

Cardiovascular disease; Gout; Hyperuricemia; Xanthine oxidase inhibitor

Indexed keywords

ALLOPURINOL; FEBUXOSTAT; URIC ACID; XANTHINE OXIDASE INHIBITOR;

EID: 84876913617     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2013.790804     Document Type: Review
Times cited : (34)

References (91)
  • 1
    • 0000009816 scopus 로고
    • Serum uric acid in relation to age and physique in health and coronary heart disease
    • Gertler M, Garn S, Levine S. Serum uric acid in relation to age and physique in health and coronary heart disease. Ann Intern Med 1951;34:1421-31
    • (1951) Ann Intern Med , vol.34 , pp. 1421-1431
    • Gertler, M.1    Garn, S.2    Levine, S.3
  • 2
    • 85047692424 scopus 로고
    • Serum uric acid: Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia
    • Klein R, Klein B, Cornoni J, et al. Serum uric acid: its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 1973;132:401-10
    • (1973) Arch Intern Med , vol.132 , pp. 401-410
    • Klein, R.1    Klein, B.2    Cornoni, J.3
  • 3
    • 1542510891 scopus 로고    scopus 로고
    • Uric acid: Role in cardiovascular disease and effects of losartan
    • DOI 10.1185/030079904125002982
    • Alderman M, Aiyer KJ. Uric acid: role in cardiovascular disease and effects of losartan. Curr Med Res Opin 2004;20:369-79 (Pubitemid 38339177)
    • (2004) Current Medical Research and Opinion , vol.20 , Issue.3 , pp. 369-379
    • Alderman, M.1    Aiyer, K.J.V.2
  • 4
    • 0344199826 scopus 로고    scopus 로고
    • Is raised serum uric acid a cause of cardiovascular disease or death?
    • DOI 10.1016/S0140-6736(99)00260-3
    • Dobson A. Is raised serum uric acid a cause of cardiovascular disease or death? Lancet 1999;354:1578 (Pubitemid 29515947)
    • (1999) Lancet , vol.354 , Issue.9190 , pp. 1578
    • Dobson, A.1
  • 5
    • 11244253742 scopus 로고    scopus 로고
    • Resurrection of uric acid as a causal risk factor in essential hypertension
    • DOI 10.1161/01.HYP.0000150785.39055.e8
    • Johnson RJ, Feig DI, Herrera-Acosta J, et al. Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 2005;45:18-20 (Pubitemid 40066407)
    • (2005) Hypertension , vol.45 , Issue.1 , pp. 18-20
    • Johnson, R.J.1    Feig, D.I.2    Herrera-Acosta, J.3    Kang, D.-H.4
  • 6
    • 0036558561 scopus 로고    scopus 로고
    • Urate levels as a predictor of cardiac deaths: Causal relation or mere association?
    • DOI 10.1053/euhj.2001.3126
    • Yusuf S, Bosch J. Urate levels as a predictor of cardiac deaths: causal relation or mere association? Eur Heart J 2002;23:760-1 (Pubitemid 35238485)
    • (2002) European Heart Journal , vol.23 , Issue.10 , pp. 760-761
    • Yusuf, S.1    Bosch, J.2
  • 7
    • 0033670512 scopus 로고    scopus 로고
    • Relation between serum uric acid and risk of cardiovascular disease in essential hypertension
    • Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000;36:1072-8
    • (2000) The PIUMA Study. Hypertension , vol.36 , pp. 1072-1078
    • Verdecchia, P.1    Schillaci, G.2    Reboldi, G.3
  • 9
    • 84858698191 scopus 로고    scopus 로고
    • Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey 1999-2006
    • Loeffler LF, Navas-Acien A, Brady TM, et al. Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006. Hypertension 2012;59:811-17
    • (2012) Hypertension , vol.59 , pp. 811-817
    • Loeffler, L.F.1    Navas-Acien, A.2    Brady, T.M.3
  • 10
    • 34447318846 scopus 로고    scopus 로고
    • Association between serum uric acid and prehypertension among US adults
    • DOI 10.1097/HJH.0b013e32813aeb6c, PII 0000487220070800000010
    • Syamala S, Li J, Shankar A. Association between serum uric acid and prehypertension among US adults. J Hypertens 2007;25:1583-9 (Pubitemid 47056563)
    • (2007) Journal of Hypertension , vol.25 , Issue.8 , pp. 1583-1589
    • Syamala, S.1    Li, J.2    Shankar, A.3
  • 12
    • 0041402693 scopus 로고    scopus 로고
    • Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke
    • Weir CJ, Muir SW, Walters MR, et al. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003;34:1951-7
    • (2003) Stroke , vol.34 , pp. 1951-1957
    • Weir, C.J.1    Muir, S.W.2    Walters, M.R.3
  • 14
    • 84872094694 scopus 로고    scopus 로고
    • An association between uric acid levels and renal arteriolopathy in chronic kidney disease: A biopsy-based study
    • Kohagura K, Kochi M, Miyagi T, et al. An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study. Hypertens Res 2013;36:43-9
    • (2013) Hypertens Res , vol.36 , pp. 43-49
    • Kohagura, K.1    Kochi, M.2    Miyagi, T.3
  • 15
    • 79251557504 scopus 로고    scopus 로고
    • Uric acid as a predictor of all-cause mortality in heart failure: A meta-analysis
    • Tamariz L, Harzand A, Palacio A, et al. Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis. Congestive Heart Failure 2011;17:25-30
    • (2011) Congestive Heart Failure , vol.17 , pp. 25-30
    • Tamariz, L.1    Harzand, A.2    Palacio, A.3
  • 17
    • 18244367869 scopus 로고    scopus 로고
    • Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: Prospective study and meta-analysis
    • Wheeler JG, Juzwishin KD, Eiriksdottir G, et al. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med 2005;2:e76
    • (2005) PLoS Med , vol.2
    • Wheeler, J.G.1    Juzwishin, K.D.2    Eiriksdottir, G.3
  • 18
    • 84859960120 scopus 로고    scopus 로고
    • Novara Atherosclerosis Study Group (NAS). Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study
    • De Luca G, Secco GG, Santagostino M, et al; Novara Atherosclerosis Study Group (NAS). Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study. Nutr Metab Cardiovasc Dis 2012;22:426-33
    • (2012) Nutr Metab Cardiovasc Dis , vol.22 , pp. 426-433
    • De Luca, G.1    Secco, G.G.2    Santagostino, M.3
  • 19
    • 27944465651 scopus 로고    scopus 로고
    • Serum uric acid and risk of coronary heart disease
    • DOI 10.2174/138161205774913200
    • Wannamethee SG. Serum uric acid and risk of coronary heart disease. Curr Pharm Des 2005;11:4125-32 (Pubitemid 41672461)
    • (2005) Current Pharmaceutical Design , vol.11 , Issue.32 , pp. 4125-4132
    • Wannamethee, S.G.1
  • 20
    • 39549086157 scopus 로고    scopus 로고
    • Uric acid administration in patients with acute stroke: A novel approach to neuroprotection
    • DOI 10.1586/14737175.8.2.259
    • Amaro S, Planas AM, Chamorro A. Uric acid administration in patients with acute stroke: a novel approach to neuroprotection. Expert Rev Neurother 2008;8:259-70 (Pubitemid 351281113)
    • (2008) Expert Review of Neurotherapeutics , vol.8 , Issue.2 , pp. 259-270
    • Amaro, S.1    Planas, A.M.2    Chamorro, A.3
  • 21
    • 23244462442 scopus 로고    scopus 로고
    • Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
    • DOI 10.1016/j.amjmed.2005.03.043, PII S0002934305003426
    • Baker JF, Krishnan E, Chen L, et al. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005;118:816-26 (Pubitemid 41097455)
    • (2005) American Journal of Medicine , vol.118 , Issue.8 , pp. 816-826
    • Baker, J.F.1    Krishnan, E.2    Chen, L.3    Schumacher, H.R.4
  • 24
    • 80054069941 scopus 로고    scopus 로고
    • Xanthine oxidase and uric acid in cardiovascular disease: Clinical impact and therapeutic options
    • Doehner W, Landmesser U. Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options. Semin Nephrol 2011;31: 433-40
    • (2011) Semin Nephrol , vol.31 , pp. 433-440
    • Doehner, W.1    Landmesser, U.2
  • 26
  • 28
    • 34548142983 scopus 로고    scopus 로고
    • Independent impact of gout on mortality and risk for coronary heart disease
    • DOI 10.1161/CIRCULATIONAHA.107.703389, PII 0000301720070821000006
    • Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007;116:894-900 (Pubitemid 47300913)
    • (2007) Circulation , vol.116 , Issue.8 , pp. 894-900
    • Choi, H.K.1    Curhan, G.2
  • 29
    • 77953479639 scopus 로고    scopus 로고
    • Gout: An independent risk factor for all-cause and cardiovascular mortality
    • Kuo CF, See LC, Luo SF, et al. Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology 2010;49:141-6
    • (2010) Rheumatology , vol.49 , pp. 141-146
    • Kuo, C.F.1    See, L.C.2    Luo, S.F.3
  • 30
    • 62549112964 scopus 로고    scopus 로고
    • Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: A Chinese cohort study
    • Chen JH, Chuang SY, Chen HJ, et al. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Care Res 2009;61:225-32
    • (2009) Arthritis Care Res , vol.61 , pp. 225-232
    • Chen, J.H.1    Chuang, S.Y.2    Chen, H.J.3
  • 31
    • 39749157632 scopus 로고    scopus 로고
    • Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A Preventive Cardiology Information System (PreCIS) database cohort study
    • DOI 10.1002/art.23121
    • Ioachimescu AG, Brennan DM, Hoar BM, et al. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 2008;58:623-30 (Pubitemid 351294901)
    • (2008) Arthritis and Rheumatism , vol.58 , Issue.2 , pp. 623-630
    • Ioachimescu, A.G.1    Brennan, D.M.2    Hoar, B.M.3    Hazen, S.L.4    Hoogwerf, B.J.5
  • 32
    • 0034630917 scopus 로고    scopus 로고
    • Serum uric acid and cardiovascular mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992
    • Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404-10 (Pubitemid 30257539)
    • (2000) Journal of the American Medical Association , vol.283 , Issue.18 , pp. 2404-2410
    • Fang, J.1    Alderman, M.H.2
  • 34
    • 0032791505 scopus 로고    scopus 로고
    • Serum uric acid and cardiovascular events in successfully treated hypertensive patients
    • Alderman MH, Cohen H, Madhavan S, et al. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999;34:144-50 (Pubitemid 29325733)
    • (1999) Hypertension , vol.34 , Issue.1 , pp. 144-150
    • Alderman, M.H.1    Cohen, H.2    Madhavan, S.3    Kivlighn, S.4
  • 35
    • 0033800597 scopus 로고    scopus 로고
    • Antioxidant profile and early outcome in Stroke patients
    • Cherubini A, Polidori MC, Bregnocchi M, et al. Antioxidant profile and early outcome in Stroke patients. Stroke 2000;31:2295-300
    • (2000) Stroke , vol.31 , pp. 2295-2300
    • Cherubini, A.1    Polidori, M.C.2    Bregnocchi, M.3
  • 36
    • 79551674574 scopus 로고    scopus 로고
    • Prevalence of contraindications and prescription of pharmacologic therapies for gout
    • Keenan RT, O'Brien WR, Lee KH, et al. Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med 2011; 124:155-63
    • (2011) Am J Med , vol.124 , pp. 155-163
    • Keenan, R.T.1    O'Brien, W.R.2    Lee, K.H.3
  • 37
    • 84862643926 scopus 로고    scopus 로고
    • Elevated uric acid, the metabolic syndrome and cardiovascular disease: Cause, consequence, or just a not so innocent bystander?
    • Santos RD. Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander? Endocrine 2012;41:350-2
    • (2012) Endocrine , vol.41 , pp. 350-352
    • Santos, R.D.1
  • 38
    • 79959424654 scopus 로고    scopus 로고
    • From risk factor assessment to cardiovascular disease risk and mortality modification: The first 40 years of the Brisighella Heart Study
    • Cicero AFG, Dormi A, D'Addato S, Borghi C. From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study. Clinical Lipidology 2011;6:269-76
    • (2011) Clinical Lipidology , vol.6 , pp. 269-276
    • Cicero, A.F.G.1    Dormi, A.2    D'Addato, S.3    Borghi, C.4
  • 39
    • 84862648876 scopus 로고    scopus 로고
    • Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome
    • Gonç alves JP, Oliveira A, Severo M, et al. Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine 2012;41:450-7
    • (2012) Endocrine , vol.41 , pp. 450-457
    • Gonçalves, J.P.1    Oliveira, A.2    Severo, M.3
  • 41
    • 0141962657 scopus 로고    scopus 로고
    • Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation
    • DOI 10.1161/01.HYP.0000091371.53502.D3
    • Masuo K, Kawaguchi H, Mikami H, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003;42:474-80 (Pubitemid 37237341)
    • (2003) Hypertension , vol.42 , Issue.4 , pp. 474-480
    • Masuo, K.1    Kawaguchi, H.2    Mikami, H.3    Ogihara, T.4    Tuck, M.L.5
  • 42
    • 34548739656 scopus 로고    scopus 로고
    • Relationship between hyperuricemia and body fat distribution
    • DOI 10.2169/internalmedicine.46.0045
    • Hikita M, Ohno I, Mori Y, et al. Relationship between hyperuricemia and body fat distribution. Intern Med 2007;46:1353-8 (Pubitemid 47455757)
    • (2007) Internal Medicine , vol.46 , Issue.17 , pp. 1353-1358
    • Hikita, M.1    Ohno, I.2    Mori, Y.3    Ichida, K.4    Yokose, T.5    Hosoya, T.6
  • 43
    • 0028939936 scopus 로고
    • Sympathetic activation in obese normotensive subjects
    • Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation in obese normotensive subjects. Hypertension 1995;25(4 Pt 1):560-3
    • (1995) Hypertension , vol.25 , Issue.4 PART 1 , pp. 560-563
    • Grassi, G.1    Seravalle, G.2    Cattaneo, B.M.3
  • 44
    • 84884704487 scopus 로고    scopus 로고
    • Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study
    • May 25 [Epub ahead of print]
    • Bombelli M, Facchetti R, Fodri D et al. Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: data from the PAMELA study. Nutr Metab Cardiovasc Dis 2012 May 25 [Epub ahead of print]
    • (2012) Nutr Metab Cardiovasc Dis
    • Bombelli, M.1    Facchetti, R.2    Fodri, D.3
  • 45
    • 0037024270 scopus 로고    scopus 로고
    • Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: Results from 2 placebo-controlled studies
    • DOI 10.1161/01.CIR.0000017502.58595.ED
    • Doehner V, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebocontrolled studies. Circulation 2002;105:2619-24 (Pubitemid 34596038)
    • (2002) Circulation , vol.105 , Issue.22 , pp. 2619-2624
    • Doehner, W.1    Schoene, N.2    Rauchhaus, M.3    Leyva-Leon, F.4    Pavitt, D.V.5    Reaveley, D.A.6    Schuler, G.7    Coats, A.J.S.8    Anker, S.D.9    Hambrecht, R.10
  • 47
    • 84868202490 scopus 로고    scopus 로고
    • Uric acid reduction rectifies prehypertension in obese adolescents
    • Soletsky B, Feig DI. Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension 2012;60:1148-56
    • (2012) Hypertension , vol.60 , pp. 1148-1156
    • Soletsky, B.1    Feig, D.I.2
  • 48
    • 67650074894 scopus 로고    scopus 로고
    • Allopurinol and mortality in hyperuricaemic patients
    • Luk AJ, Levin GP, Moore EE, et al. Allopurinol and mortality in hyperuricaemic patients. Rheumatology 2009;48:804-6
    • (2009) Rheumatology , vol.48 , pp. 804-806
    • Luk, A.J.1    Levin, G.P.2    Moore, E.E.3
  • 49
    • 79952608393 scopus 로고    scopus 로고
    • Impact of allopurinol use on urate concentration and cardiovascular outcome
    • Wei L, Mackenzie IS, Chen Y, et al. Impact of allopurinol use on urate concentration and cardiovascular outcome. Br J Clin Pharmacol 2011;71:600-7
    • (2011) Br J Clin Pharmacol , vol.71 , pp. 600-607
    • Wei, L.1    MacKenzie, I.S.2    Chen, Y.3
  • 50
    • 0142182438 scopus 로고    scopus 로고
    • Allopurinol as a Cardioprotectant During Coronary Artery Bypass Graft Surgery
    • DOI 10.1345/aph.1D023
    • Weimert NA, Tanke WF, Sims JJ. Allopurinol as a cardioprotective during coronary artery bypass graft surgery. Ann Pharmacother 2003;37:1708-11 (Pubitemid 37315114)
    • (2003) Annals of Pharmacotherapy , vol.37 , Issue.11 , pp. 1708-1711
    • Weimert, N.A.1    Tanke, W.F.2    Sims, J.J.3
  • 52
    • 80054113660 scopus 로고    scopus 로고
    • Effects of urate lowering therapy on cardiovascular mortality: A Taiwanese cohort study
    • Chen J-H, Pan W-H. Effects of urate lowering therapy on cardiovascular mortality: a Taiwanese cohort study. Arthritis Rheum 2010;62:S872-3
    • (2010) Arthritis Rheum , vol.62
    • Chen, J.-H.1    Pan, W.-H.2
  • 53
    • 77955442528 scopus 로고    scopus 로고
    • Gout, allopurinol use, and heart failure outcomes
    • Thanassoulis G, Brophy JM, Richard H, et al. Gout, allopurinol use, and heart failure outcomes. Arch Intern Med 2010;170:1358-64
    • (2010) Arch Intern Med , vol.170 , pp. 1358-1364
    • Thanassoulis, G.1    Brophy, J.M.2    Richard, H.3
  • 55
    • 12344285284 scopus 로고    scopus 로고
    • Uric acid in chronic heart failure
    • DOI 10.1016/j.semnephrol.2004.09.010, PII S0270929504001536, Uric Acid in Cardiovascular and Renal Disease
    • Doehner W, Anker SD. Uric acid in chronic heart failure. Semin Nephrol 2005;25:61-6 (Pubitemid 40128150)
    • (2005) Seminars in Nephrology , vol.25 , Issue.1 , pp. 61-66
    • Doehner, W.1    Anker, S.D.2
  • 56
    • 0021870226 scopus 로고
    • Systemic response to local urate crystal induced inflammation in man: A possible model to study the acute phase response
    • Hutton CW, Collins AJ, Chambers RE, et al. Systemic response to local urate crystal induced inflammation in man: a possible model to study the acute phase response. Ann Rheum Dis 1985;44:533-6 (Pubitemid 15001293)
    • (1985) Annals of the Rheumatic Diseases , vol.44 , Issue.8 , pp. 533-536
    • Hutton, C.W.1    Collins, A.J.2    Chambers, R.E.3
  • 57
    • 77949658727 scopus 로고    scopus 로고
    • Association of serum uric acid with aortic stiffness and pressure in a Chinese workplace setting
    • Chen X, Li Y, Sheng CS, et al. Association of serum uric acid with aortic stiffness and pressure in a Chinese workplace setting. Am J Hypertens 2010;23:387-92
    • (2010) Am J Hypertens , vol.23 , pp. 387-392
    • Chen, X.1    Li, Y.2    Sheng, C.S.3
  • 58
    • 78650295009 scopus 로고    scopus 로고
    • Association of serum uric acid level with aortic stiffness and arterial wave reflections in newly diagnosed, never-treated hypertension
    • Vlachopoulos C, Xaplanteris P, Vyssoulis G, et al. Association of serum uric acid level with aortic stiffness and arterial wave reflections in newly diagnosed, never-treated hypertension. Am J Hypertens 2011;24:33-9
    • (2011) Am J Hypertens , vol.24 , pp. 33-39
    • Vlachopoulos, C.1    Xaplanteris, P.2    Vyssoulis, G.3
  • 59
    • 31944445992 scopus 로고    scopus 로고
    • Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension
    • DOI 10.1161/01.HYP.0000200033.14574.14
    • Iwashima Y, Horio T, Kamide K, et al. Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertension 2006;47:195-202 (Pubitemid 43189763)
    • (2006) Hypertension , vol.47 , Issue.2 , pp. 195-202
    • Iwashima, Y.1    Horio, T.2    Kamide, K.3    Rakugi, H.4    Ogihara, T.5    Kawano, Y.6
  • 61
    • 34248643147 scopus 로고    scopus 로고
    • Lack of Association Between Serum Uric Acid and Organ Damage in a Never-Treated Essential Hypertensive Population at Low Prevalence of Hyperuricemia
    • DOI 10.1016/j.amjhyper.2007.01.013, PII S0895706107000623
    • Cuspidi C, Valerio C, Sala C, et al. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. Am J Hypertens 2007;20:678-85 (Pubitemid 46777264)
    • (2007) American Journal of Hypertension , vol.20 , Issue.6 , pp. 678-685
    • Cuspidi, C.1    Valerio, C.2    Sala, C.3    Meani, S.4    Esposito, A.5    Zanchetti, A.6    Mancia, G.7
  • 64
    • 1642484244 scopus 로고    scopus 로고
    • Xanthine oxidoreductase and cardiovascular disease: Molecular mechanisms and pathophysiological implications
    • DOI 10.1113/jphysiol.2003.055913
    • Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol (Lond) 2004;555:589-606 (Pubitemid 38404582)
    • (2004) Journal of Physiology , vol.555 , Issue.3 , pp. 589-606
    • Berry, C.E.1    Hare, J.M.2
  • 65
    • 84861502810 scopus 로고    scopus 로고
    • Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease
    • Yelken B, Caliskan Y, Gorgulu N, et al. Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease. Clin Nephrol 2012;77:275-82
    • (2012) Clin Nephrol , vol.77 , pp. 275-282
    • Yelken, B.1    Caliskan, Y.2    Gorgulu, N.3
  • 66
    • 33845447368 scopus 로고    scopus 로고
    • High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid
    • DOI 10.1161/CIRCULATIONAHA.106.651117, PII 0000301720061205000014
    • George J, Carr E, Davies J, et al. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006;114:2508-16 (Pubitemid 44901524)
    • (2006) Circulation , vol.114 , Issue.23 , pp. 2508-2516
    • George, J.1    Carr, E.2    Davies, J.3    Belch, J.J.F.4    Struthers, A.5
  • 68
    • 34547733397 scopus 로고    scopus 로고
    • Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress
    • DOI 10.1152/ajpcell.00600.2006
    • Sautin YY, Nakagawa T, Zharikov S, et al Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/ nitrosative stress. Am J Physiol Cell Physiol 2007;293:C584-96 (Pubitemid 47235197)
    • (2007) American Journal of Physiology - Cell Physiology , vol.293 , Issue.2
    • Sautin, Y.Y.1    Nakagawa, T.2    Zharikov, S.3    Johnson, R.J.4
  • 69
    • 79952745185 scopus 로고    scopus 로고
    • Xanthine-oxidase inhibitors and statins in chronic heart failure: Effects on vascular and functional parameters
    • Greig D, Alcaino H, Castro PF, et al. Xanthine-oxidase inhibitors and statins in chronic heart failure: effects on vascular and functional parameters. J Heart Lung Transplant 2011;30:408-13
    • (2011) J Heart Lung Transplant , vol.30 , pp. 408-413
    • Greig, D.1    Alcaino, H.2    Castro, P.F.3
  • 70
    • 79958132608 scopus 로고    scopus 로고
    • Uric acid as a cardiometabolic risk factor: To be or not to be
    • Kanbay M, Afsar B, Covic A. Uric acid as a cardiometabolic risk factor: to be or not to be. Contrib Nephrol 2011;171:62-7
    • (2011) Contrib Nephrol , vol.171 , pp. 62-67
    • Kanbay, M.1    Afsar, B.2    Covic, A.3
  • 71
    • 47049099695 scopus 로고    scopus 로고
    • The role of urate and xanthine oxidase inhibitors in cardiovascular disease
    • DOI 10.1111/j.1527-3466.2007.00029.x
    • George J, Struthers AD. The role of urate and xanthine oxidase inhibitors in cardiovascular disease. Cardiovasc Therapeut 2008;26:59-64 (Pubitemid 351421775)
    • (2008) Cardiovascular Therapeutics , vol.26 , Issue.1 , pp. 59-64
    • George, J.1    Struthers, A.D.2
  • 72
    • 0035199068 scopus 로고    scopus 로고
    • Uric acid is closely linked to vascular nitric oxide activity: Evidence for mechanism of association with cardiovascular disease
    • DOI 10.1016/S0735-1097(01)01643-6, PII S0735109701016436
    • Maxwell AJ, Bruinsma KA. Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol 2001;38:1850-8 (Pubitemid 33116554)
    • (2001) Journal of the American College of Cardiology , vol.38 , Issue.7 , pp. 1850-1858
    • Maxwell, A.J.1    Bruinsma, K.A.2
  • 73
    • 0037047070 scopus 로고    scopus 로고
    • Allopurinol improves endothelial dysfunction in chronic heart failure
    • DOI 10.1161/01.CIR.0000022140.61460.1D
    • Farquharson CAR, Hill A, Belch JJ, et al. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002;106:221-6 (Pubitemid 34761303)
    • (2002) Circulation , vol.106 , Issue.2 , pp. 221-226
    • Farquharson, C.A.J.1    Butler, R.2    Hill, A.3    Belch, J.J.F.4    Struthers, A.D.5
  • 74
    • 1442348765 scopus 로고    scopus 로고
    • Role of xanthine oxidase in conduit artery endothelial dysfunction in cigarette smokers
    • DOI 10.1016/j.amjcard.2003.11.046, PII S000291490301676X
    • Guthikonda S, Woods K, Sinkey CA, et al. Role of xanthine oxidase in conduit artery endothelial dysfunction in cigarette smokers. Am J Cardiol 2004;93:664-8 (Pubitemid 38293087)
    • (2004) American Journal of Cardiology , vol.93 , Issue.5 , pp. 664-668
    • Guthikonda, S.1    Woods, K.2    Sinkey, C.A.3    Haynes, W.G.4
  • 80
    • 33748116331 scopus 로고    scopus 로고
    • The Effect of Xanthine Oxidase Inhibition Upon Ejection Fraction in Heart Failure Patients: La Plata Study
    • DOI 10.1016/j.cardfail.2006.05.005, PII S1071916406002557
    • Cingolani HE, Plastino JA, Escudero EM, et al. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata study. J Card Fail 2006;12:491-8 (Pubitemid 44307706)
    • (2006) Journal of Cardiac Failure , vol.12 , Issue.7 , pp. 491-498
    • Cingolani, H.E.1    Plastino, J.A.2    Escudero, E.M.3    Mangal, B.4    Brown, J.5    Perez, N.G.6
  • 82
    • 76549098607 scopus 로고    scopus 로고
    • Uric acid-lowering treatment with benzbromarone in patients with heart failure: A double-blind placebo-controlled crossover preliminary study
    • Ogino K, Kato M, Furuse Y, et al. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail 2010;3:73-81
    • (2010) Circ Heart Fail , vol.3 , pp. 73-81
    • Ogino, K.1    Kato, M.2    Furuse, Y.3
  • 83
    • 84861189813 scopus 로고    scopus 로고
    • Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition
    • Harzand A, Tamariz L, Hare JM. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition. Congest Heart Fail 2012;18:179-82
    • (2012) Congest Heart Fail , vol.18 , pp. 179-182
    • Harzand, A.1    Tamariz, L.2    Hare, J.M.3
  • 84
    • 0036180824 scopus 로고    scopus 로고
    • Effect of allopurinol on mortality and hospitalisations in chronic heart failure: A retrospective cohort study
    • Struthers AD, Donnan PT, Lindsay P, et al. Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study. Heart 2002;87:229-34 (Pubitemid 34177675)
    • (2002) Heart , vol.87 , Issue.3 , pp. 229-234
    • Struthers, A.D.1    Donnan, P.T.2    Lindsay, P.3    McNaughton, D.4    Broomhall, J.5    MacDonald, T.M.6
  • 85
    • 80054021686 scopus 로고    scopus 로고
    • Allopurinol as a cardiovascular drug
    • Kelkar A, Kuo A, Frishman WH. Allopurinol as a cardiovascular drug. Cardiol Rev 2011;19:265-71
    • (2011) Cardiol Rev , vol.19 , pp. 265-271
    • Kelkar, A.1    Kuo, A.2    Frishman, W.H.3
  • 86
    • 80051616824 scopus 로고    scopus 로고
    • Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris
    • Rajendra NS, Ireland S, George J, et al. Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. J Am Coll Cardiol 2011;58:820-8
    • (2011) J Am Coll Cardiol , vol.58 , pp. 820-828
    • Rajendra, N.S.1    Ireland, S.2    George, J.3
  • 87
    • 79960141065 scopus 로고    scopus 로고
    • Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease
    • Kao MP, Ang DS, Gandy SJ, et al. Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol 2011;22:1382-9
    • (2011) J Am Soc Nephrol , vol.22 , pp. 1382-1389
    • Kao, M.P.1    Ang, D.S.2    Gandy, S.J.3
  • 88
    • 79957951218 scopus 로고    scopus 로고
    • Febuxostat inhibition of endothelialbound XO: Implications for targeting vascular ROS production
    • Malik UZ, Hundley NJ, Romero G, et al. Febuxostat inhibition of endothelialbound XO: implications for targeting vascular ROS production. Free Radic Biol Med 2011;51:179-84
    • (2011) Free Radic Biol Med , vol.51 , pp. 179-184
    • Malik, U.Z.1    Hundley, N.J.2    Romero, G.3
  • 90
    • 58149328542 scopus 로고    scopus 로고
    • Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: A randomized, double-blind, placebo-controlled trial
    • Muir SW, Harrow C, Dawson J, et al. Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke 2008;39:3303-7
    • (2008) Stroke , vol.39 , pp. 3303-3307
    • Muir, S.W.1    Harrow, C.2    Dawson, J.3
  • 91
    • 84863479133 scopus 로고    scopus 로고
    • Xanthine oxidase inhibition for the treatment of cardiovascular disease: A systematic review and meta-analysis
    • Higgins P, Dawson J, Lees KR, et al. Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovasc Ther 2012;30:217-26
    • (2012) Cardiovasc Ther , vol.30 , pp. 217-226
    • Higgins, P.1    Dawson, J.2    Lees, K.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.